Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations

Vaccine Preventable Disease Clinical Trial

— CERC  

Official title:

Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With Minority Populations

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04765839
• Other study ID #: 21-000205
• Status: Completed
• Phase: N/A
• Start date: February 12, 2021
• Est. completion date: April 3, 2021

Study information

• Verified date: July 2021
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A cluster randomized trial will be conducted prior to widespread vaccine availability to the general public. Community-informed COVID-19 vaccine messages will be disseminated to participants. At baseline, 2 weeks and 4 weeks, the study team will survey participants to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated.

Description:

A cluster randomized trial with 80 participants from the social networks of 8 CLs will be conducted prior to widespread vaccine availability to the general public. Four CLs and social networks (cluster of 10 per network) will be randomly assigned to receive the intervention immediately or after a delay of 2 weeks. Intervention participants will be invited to a closed social media group on the platform of their choice. CLs, selected for trustworthiness within vulnerable populations, will disseminate community-informed COVID-19 vaccine messages to members of their social networks and engage in bidirectional communication with CEnR partners to refine messages. At baseline, 2 weeks and 4 weeks, participants will be surveyed to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 74
• Est. completion date: April 3, 2021
• Est. primary completion date: April 3, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 101 Years

Eligibility

Inclusion Criteria:

• Self-identification within a CLs social network
• Age 18 or greater
• Functional internet access.

Exclusion Criteria:

• Does not self-identify within a CLs social network
• Is under the age of 18
• Does not have functional internet access.

Related Conditions & MeSH terms

• Emergencies
• Vaccine Preventable Disease

Intervention

Other:
• Educational, culturally appropriate COVID-19 messages
Educational, culturally appropriate COVID-19 messages will be developed and shared by RHCP.

Locations

Country	Name	City	State
United States	Mayo Clinic	Rochester	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	COVID-19 attitudes	Related to perceived susceptibility and preventive measures will be assessed through 3 survey instruments, based on 7-point Likert scale.	4 weeks